Evaluation of T1-weighted MRI to detect intratumoral hemorrhage within papillary renal cell carcinoma as a feature differentiating from angiomyolipoma without visible …

CA Murray, M Quon, MDF McInnes… - American Journal of …, 2016 - Am Roentgen Ray Soc
American Journal of Roentgenology, 2016Am Roentgen Ray Soc
OBJECTIVE. The objective of the present study is to determine whether hemorrhage within
papillary renal cell carcinoma (RCC) can be detected using T1-weighted MRI and to
ascertain whether it can be used to differentiate papillary RCC from angiomyolipoma (AML)
without visible fat. MATERIALS AND METHODS. A retrospective case-control study
compared 11 AMLs without visible fat with 58 papillary RCCs smaller than 5 cm that were
evaluated using MRI between 2003 and 2015. Two blinded radiologists subjectively …
OBJECTIVE. The objective of the present study is to determine whether hemorrhage within papillary renal cell carcinoma (RCC) can be detected using T1-weighted MRI and to ascertain whether it can be used to differentiate papillary RCC from angiomyolipoma (AML) without visible fat.
MATERIALS AND METHODS. A retrospective case-control study compared 11 AMLs without visible fat with 58 papillary RCCs smaller than 5 cm that were evaluated using MRI between 2003 and 2015. Two blinded radiologists subjectively evaluated MR images to identify the presence of intratumoral hemorrhage on the basis of a decrease in signal intensity (SI) on in-phase, compared with opposed-phase, chemical-shift MRI and also on the basis of the SI of the lesion compared with that of the renal cortex on fat-suppressed T1-weighted MRI. A third radiologist established consensus and measured the ratio of the SI of the lesion to that of the renal cortex (hereafter referred to as the “SI ratio”) on T2-weighted MRI; the SI loss index, as calculated using the equation [(SItumorIP − SItumorOP) / SItumorOP] × 100, where IP denotes the in-phase image and OP denotes the opposed-phase image; and the SI ratio on fat-suppressed T1-weighted MRI. Analyses were performed using tests of association and ROCs.
RESULTS. When AMLs without visible fat were compared with papillary RCCs, no statistically significant difference in the T2-weighted SI ratio was noted (p = 0.08). Papillary RCCs had a lower mean (± SD) SI loss index (−3.7% ± 17.3%; range, −51.3% to 31.3%) than did AMLs without visible fat (37.8% ± 76.1%; range, −15.6% to 184.4%) (p < 0.001). A mean SI loss index of less than −16% resulted in an AUC of 0.71 (95% CI, 0.52–0.91), with a sensitivity and specificity of 22.8% and 100%, respectively, for the diagnosis of papillary RCC. After consensus review, none of the AMLs without visible fat and 16 of the 58 papillary RCCs (27.6%) were found to have a decrease in SI on subjective analysis (p = 0.06, κ = 0.60). Between groups, no differences were noted in the SI ratio on fat-suppressed T1-weighted MRI (p = 0.58) or in the SI observed on subjective analysis of fat-suppressed T1-weighted MRI (p = 0.20, κ = 0.48).
CONCLUSION. The presence of intratumoral hemorrhage within papillary RCC is a specific feature that differentiates papillary RCCs from AMLs without visible fat. Subjective analysis may be more clinically appropriate than chemical-shift MRI because of limitations in the quantitative measurement of T2* signal with the use of chemical-shift MRI.
Am Roentgen Ray Soc
以上显示的是最相近的搜索结果。 查看全部搜索结果